Medi Assist is India's largest health insurance third-party administrator, processing claims for group, retail, government, and international health benefits, and selling a SaaS claims engine, MAtrix, with AI fraud detection. In FY26, it administered INR25,923 crores of premiums, up 22.8% YoY, with an overall market share of 20.7% in health premiums, up 115 bps. Group segment holds 33.7% share, while retail is 5% in the traditional TPA model. The business earns fees per claim and per member, with operating EBITDA margin of 19.3% in Q4 FY26, improving sequentially from 17.1% in Q2. Excluding the acquired Paramount TPA, the core margin is 21.8%, reflecting a high-quality, recurring revenue base with 93.2% group retention.
The economics persist because of deep switching costs and a two-sided network. Insurers rely on Medi Assist for claims processing, fraud detection, and cashless discharge across 6,000 hospitals. The MAtrix platform now manages over INR18,000 crores of retail premiums, representing 32% of industry retail premiums, and is live with three leading private insurers. AI tools like MAven Guard prevented INR540 crores of fraud in FY26, while network discounts delivered INR1,300 crores. These capabilities are not easily replicated; the company has 31 domestic and 5 international insurer relationships, and its government business serves 27 crore members across 13 states. The 94%+ historical retention rate confirms that once a corporate or insurer is onboarded, they rarely leave.
The inflection is the Paramount TPA integration and the scaling of technology. Over 50% of Paramount claims volume has already migrated to MAtrix, with the platform targeted to become the primary processing engine before Q2 FY27. The slump transfer of Paramount operations to Medi Assist TPA was completed on February 1, 2026, creating a single unified entity. By 18-24 months from now, the integration should be fully complete, with Paramount's margin drag eliminated. Technology revenues grew 91.9% in FY26 to INR21.7 crores, and management expects similar growth rates to continue, driven by international expansion and platform-led growth. The Thailand partnership alone provides access to over US$50 million of group premiums. With the balance sheet debt-free since January 2026 and free cash flow of INR260.5 crores, the company can fund these initiatives without dilution. The 18-24 month picture is a business with technology revenues potentially doubling again, core TPA margins at 23-24%, and a diversified mix across group, government, international, and SaaS.
Management has a track record of delivering on promises. They guided to a 23-24% steady-state EBITDA margin for the core TPA business in August 2025, and delivered 21.8% ex-Paramount in Q3 FY26. They flagged a 200-250 bps near-term drag from Paramount consolidation, but narrowed the shortfall from -6.4% to -0.9% in two quarters. Revenue growth of 24% in 9M FY26 exceeded the industry's ~20% premium growth. They promised debt-free status by January 2026 and achieved it. Contract liability (unearned revenue) stood at INR280.2 crores as of March 31, 2026, providing visibility. Capital allocation is conservative: no dilution, net cash positive, and investments in technology and global partnerships. The only minor miss is group retention at 93.2% versus historical 94%+, but that was a deliberate quality decision.
The quantified earnings path is clear. From a Q4 FY26 operating EBITDA margin of 19.3%, the company should reach 23-24% as Paramount synergies materialize and technology mix increases. Technology margins are 1.5-2x traditional TPA, so every 10% shift in revenue mix adds roughly 50-100 bps to blended margin. With revenue growth expected to continue at industry rate or faster, and technology growing at 80-90%+, EBITDA could grow from INR174.6 crores in FY26 to over INR250 crores in FY28. The key watchpoint is Paramount migration timing: if the platform does not become the primary engine by Q2 FY27, the margin recovery slips. Also, retail market share declined slightly to 5%, and industry same-store growth has slowed to 8-10% from 25% post-COVID. The falsifier would be a delay in Paramount integration or a sharp deceleration in technology revenue growth. As long as management executes on the stated timeline, the business transforms from a traditional TPA to a technology-enabled health administrator with structurally higher margins.
companyname: Medi Assist Healthcare Services Limited ticker: MEDIASSIST sector: Health Benefits Administration / Third Party Administration (TPA) / InsurTech Medi Assist is India's largest health benefits administrator, operating as the middle layer between insurance companies, hospitals, and policyholders. It administers INR25,923 crores of health insurance premiums as of March 31, 2026, processes nearly 1 million claims every month, and covers over 340 million lives across all its businesses ...
Read the full report →margin expansion, geographic expansion, acquisition inorganic, debt reduction
FY27 tech revenue growth expected to continue at similar rates as FY26 driven by international expansion and platform-led growth
Guidance no_dataconsistent
Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Medi Assist Health Ser L and 4,900+ companies.
5-day free pass. No card required.